{
    "nctId": "NCT01352598",
    "officialTitle": "Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer",
    "inclusionCriteria": "* Patient age \\>= 18 years\n* Zubrod performance status of 0-3\n* T1-3 N0 M0 adenocarcinoma of the prostate\n* Prostate volume \u2264 100 cc\n* Signed study-specific consent form\n* Must be MALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Extension of local tumor to involve adjacent organs other than seminal vesicles (T4)\n* Prostate volume \\> 100 cc\n* Nodal involvement\n* Metastatic disease\n* Prior pelvic radiotherapy except as part of combination therapy for prostate cancer\n* History of scleroderma\n* Patients with psychiatric or addictive disorder that would preclude obtaining informed consent"
}